Market Overview

Hearing Raymond James Downgraded AngioDynamics From Outperform To Market Perform


This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of headlines on any catalyst that could move the stocks you care about on Benzinga Pro, our flagship platform for fast, actionable information that promotes faster, smarter trading.

Benzinga Pro has an intuitively designed workspace that delivers powerful market insight, and is the solution of choice for thousands of professional and retail traders across the world.

Stop Googling for information and check out Benzinga Pro. You will never again be left in the dark on when a stock moves. You’ll have what you need to act in real-time — before the crowd.

Start your FREE 14-day trial of Benzinga Pro today.

Latest Ratings for ANGO

Apr 2018Raymond JamesUpgradesMarket PerformOutperform
Apr 2018Canaccord GenuityMaintainsHoldHold
Jul 2017BarclaysMaintainsEqual-Weight

View More Analyst Ratings for ANGO
View the Latest Analyst Ratings

Posted-In: Analyst Color News Rumors Analyst Ratings


Related Articles (ANGO)

Morgan Stanley Downgrades Jazz Pharmaceuticals As Stock Approaches Price Target

Earnings Preview: Peak Resorts